The Masimo trial ultimately failed to get a permanent ban on Apple Watch sales or use of the blood oxygen sensor, but the final verdict will have Apple pay $634M to Masimo’s new owner Danaher after the appeal was rejected.
Apple Watch blood oxygen detection is safe from the patent lawsuit
Apple Watch blood oxygen detection is safe from the patent lawsuit
Apple Watch users have been able to take advantage of the blood oxygen sensor in Apple Watch since a software update in January 2024 successfully bypassed a sales ban. Masimo’s attempts to reinstate a ban failed, and all that was left in the case for Apple to pay a fine.
Apple appealed the merits of the jury’s findings based on the definition of a “patient monitor.” According to a report from Law360, U.S. District Judge James V. Selna turned down Apple’s request.